Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Global Immune Technologies Acquires Solar License From Germans

LEIPZIG, GERMANY and PALMA DE MALLORCA, SPAIN--(Marketwire - Dec. 22, 2010) - The Board of Directors of Global Immune Technologies, Inc. (OTCQB:GIMU) today announces that it has executed a Purchase And Assignment Agreement with Mid Atlantic Capital Associates SL of Mallorca, Spain. The Purchase and Assignment involves the formation of a new, wholly-owned GmbH that will facilitate the Company's license and global marketing of a new, hybrid energy collection system considered the greatest innovation in solar panel technology to-date.
Institute For Applied Technology, of Leipzig, Germany is the Licensor and the Company through its German division will be actively developing markets and supplying distributors in several countries including France, Spain and the USA with further global reach as soon as finance and production facilities can be completed.
An 8K and full press release will be made shortly.
Safe Harbor Statement
This communication contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Global Immune Technologies Inc. and members of its management as well as the assumptions on which such statements are based.
Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions.
The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.